IRIS
CANEPA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.343
AS - Asia 77
SA - Sud America 34
NA - Nord America 3
AF - Africa 1
Totale 12.458
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.339
CN - Cina 53
BR - Brasile 26
SG - Singapore 13
VN - Vietnam 11
AR - Argentina 3
EC - Ecuador 2
GB - Regno Unito 2
US - Stati Uniti d'America 2
AT - Austria 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
PA - Panama 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 12.458
Salva come PNG Salva come JPEG
Città #
Genova 6.227
Genoa 3.999
Vado Ligure 1.043
Rapallo 1.034
Bordighera 33
Beijing 22
Singapore 11
Ho Chi Minh City 3
Milan 3
Ashburn 2
São Paulo 2
Anápolis 1
Auriflama 1
Biên Hòa 1
Buenos Aires 1
Bạc Liêu 1
Cape Town 1
Concórdia 1
Coxilha 1
Cuenca 1
Curitiba 1
Da Nang 1
Dosquebradas 1
Fernando de la Mora 1
Franco da Rocha 1
Hanoi 1
Hải Dương 1
Jaguariaíva 1
Jaraguá do Sul 1
Jaú 1
Lấp Vò 1
Macapá 1
Marília 1
Norwich 1
Olivos 1
Panama City 1
Paulista 1
Pelotas 1
Phủ Lý 1
Porto Alegre 1
Recreio 1
Ribeirão Preto 1
Rio de Janeiro 1
San Bernardo 1
San Luis 1
Santa Isabel do Pará 1
Santos 1
Shanghai 1
Sumaré 1
Suzano 1
São Gonçalo 1
São Leopoldo 1
São Manuel 1
Thái Bình 1
Vienna 1
Totale 12.423
Salva come PNG Salva come JPEG
Nome #
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 217
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 201
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 197
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 195
Using unsupervised learning to determine risk level for left ventricular diastolic dysfunction2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 188
E / e' ratio and outcome prediction in hypertrophic cardiomyopathy: The influence of outflow tract obstruction 177
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 174
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 169
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 168
T1 mapping with cardiovascular magnetic resonance: An emerging clinical biomarker 166
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 166
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 163
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 159
Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. 156
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry 155
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 154
[Cardiac cell therapy: the puzzle is waiting to be solved] 150
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 148
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 147
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 145
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 145
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 143
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 143
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 143
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 143
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. 140
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy 140
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 139
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 139
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 135
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial 134
The association between leptin and depressive symptoms is modulated by abdominal adiposity. 133
ECHOCARDIOGRAPHIC AND CLINICAL CORRELATES OF SPECIFIC EARLY REPOLARIZATION SUBTYPES ON ELECTROCARDIOGRAM 130
Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation 130
GENDER DIFFERENCES IN EARLY MANIFESTATIONS OF ARTERIAL STIFFNESS: RESULTS FROM THE SARDINIA PROJECT 129
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 129
What can we learn from pulmonary function testing in heart failure? 128
Linking Heart Failure to Cancer 126
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy 125
Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy 125
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 122
The Relationship Between Brain–Heart Autonomic Signaling and Aging: A Gender-Specific Longitudinal Perspective from the Baltimore Longitudinal Study on Aging 121
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 121
Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device 117
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 115
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 115
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 114
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 114
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 114
Impact of Central Obesity on the Estimation of Carotid-Femoral Pulse Wave Velocity. 113
Modes of death and prognostic outliers in chronic heart failure 113
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 112
Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging). 111
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 107
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease 106
Multiparametric vs. Inferior Vena Cava-Based Estimation of Right Atrial Pressure 106
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 105
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 104
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 104
Lower mitochondrial energy production of the thigh muscles in patients with low-normal ankle-brachial index 104
Human amniotic fluid stem cell secretome protects cardiomyocytes against doxorubicin toxicity 104
Brugada syndrome and syncope: a practical approach for diagnosis and treatment 104
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis 101
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues 98
Sometimes they come back: recurrent noncardiac right-to-left shunt after percutaneous patent foramen ovale closure. 97
Longitudinal Association between Serum Uric Acid and Arterial Stiffness: Results from the Baltimore Longitudinal Study of Aging 96
Bmi and acute kidney injury post transcatheter aortic valve replacement: Unveiling the obesity paradox 96
C–REACTIVE PROTEIN AS A PREDICTOR OF INTIMAL MEDIA THICKNESS IN A HEALTHY COMMUNITY DWELLING POPULATION OF A BROAD AGE RANGE 95
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 94
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement 91
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?] 89
Pulse wave velocity testing in the Baltimore longitudinal study of aging. 88
Cancer in chronic heart failure patients in the GISSI-HF trial 87
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 79
Pulmonary and cardiac drugs: clinically relevant interactions 79
[Clinical studies of cardiac cell therapy in Italy] 79
Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis 79
From arterial stiffness to heart failure: Still a long way to go 78
Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database 78
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 77
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials 75
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis 73
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: Lessons from the coronavirus disease 2019 lockdown in Italy 71
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co-transporter 2 inhibitors? 71
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis 71
Cardiac amyloidosis: a changing epidemiology with open challenges 69
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk Score 69
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 68
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 67
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 67
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study 66
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 64
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 64
The impossible quest to make cardiac amyloidosis diagnosis easy 63
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis 62
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 62
Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry 61
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 60
Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy 60
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 58
Totale 11.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.989
article - articoli 46.618
book - libri 0
conference - conferenze 2.371
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021885 0 0 0 176 81 51 80 113 75 133 83 93
2021/20221.148 31 28 73 106 46 108 63 276 83 117 35 182
2022/20231.246 117 119 24 122 193 186 17 88 201 10 152 17
2023/2024780 34 92 17 108 74 108 49 59 51 29 46 113
2024/20252.611 89 174 59 168 362 271 259 430 134 118 253 294
2025/20261.747 576 262 469 440 0 0 0 0 0 0 0 0
Totale 12.860